Aicha Kriaa

Mrs. Aicha Kriaa

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2019 in Catalysts
Verified
Journal Article
Open access
PDF file
AKAicha Kriaa
Aicha Kriaa
MBMélanie Bourgin
Mélanie Bourgin
HMHéla Mkaouar
Héla Mkaouar
AJAmin Jablaoui
Amin Jablaoui
NANizar Akermi
Nizar Akermi
Moez RhimiMoez Rhimi
Moez Rhimi
The gut microbiota plays a key role in cholesterol metabolism, mainly through the reduction of cholesterol to coprostanol. The latter sterol exhibits distinct physicochemical properties linked to its limited absorption in the gut. Few bacteria were reported to reduce cholesterol into coprostanol. Three microbial pathways of coprostanol production were described based on the analysis of reaction intermediates. However, these metabolic pathways and their associated genes remain poorly studied. In this review, we shed light on the microbial metabolic pathways related to coprostanol synthesis. Moreover, we highlight current strategies and future directions to better characterize these microbial enzymes and pathways.

30 August 2019 in PeerJ
Verified
Journal Article
Open access
PDF file
HMHéla Mkaouar
Héla Mkaouar
NANizar Akermi
Nizar Akermi
AKAicha Kriaa
Aicha Kriaa
AAAnne-Laure Abraham
Anne-Laure Abraham
AJAmin Jablaoui
Amin Jablaoui
RMRhimi Moez
Rhimi Moez
Serine Protease Inhibitors (Serpins) control tightly regulated physiological processes and their dysfunction is associated to various diseases. Thus, increasing interest is given to these proteins as new therapeutic targets. Several studies provided functional and structural data about human serpins. By comparison, only little knowledge regarding bacterial serpins exists. Through the emergence of metagenomic studies, many bacterial serpins were identified from numerous ecological niches including the human gut microbiota. The origin, distribution and function of these proteins remain to be established. In this report, we shed light on the key role of human and bacterial serpins in health and disease. Moreover, we analyze their function, phylogeny and ecological distribution. This review highlights the potential use of bacterial serpins to set out new therapeutic approaches.

27 March 2024 in Gut Microbes
Verified
Journal Article
Open access
AKAicha Kriaa
Aicha Kriaa
VMVincent MARIAULE
Vincent MARIAULE
CRCharlotte De Rudder
Charlotte De Rudder
AJAmin Jablaoui
Amin Jablaoui
HSHarry Sokol
Harry Sokol
RMRhimi Moez
Rhimi Moez
Chronic digestive disorders are of increasing incidence worldwide with expensive treatments and no available cure. Available therapeutic schemes mainly rely on symptom relief, with large degrees of variability in patients' response to such treatments, underlining the need for new therapeutic strategies. There are strong indications that the gut microbiota's contribution seems to be a key modulator of disease activity and patients' treatment responses. Hence, efforts have been devoted to understanding host-microbe interactions and the mechanisms underpinning such variability. Animal models, being the gold standard, provide valuable mechanistic insights into host-microbe interactions. However, they are not exempt from limitations prompting the development of alternative methods. Emerging microfluidic technologies and gut-on-chip models were shown to mirror the main features of gut physiology and disease state, reflect microbiota modification, and include functional readouts for studying host responses. In this commentary, we discuss the relevance of animal models in understanding host-microbe interactions and how gut-on-chip technology holds promises for addressing patient variability in responses to chronic digestive disease treatment.